Delica

Delica, a national high-tech enterprise, focuses on the research, development, and production of electronic diagnosis and treatment devices related to the brain. It has developed a technical combination solution for diagnosing/monitoring various diseases such as stroke, epilepsy, neurocritical care, and syncope.Technologically, the company adheres to innovative development. In recent years, Delica has collaborated with a group of top-tier hospitals and research institutions in China to undertake two key R&D projects under the National Ministry of Science and Technology. It has jointly established "Equipment Innovation and Transformation R&D Bases" with Xuanwu Hospital of Capital Medical University, the First Hospital of Jilin University, and Guangdong Provincial Hospital of Traditional Chinese Medicine.Delica is the main executor in revising the national pharmaceutical industry standards for Transcranial Doppler Ultrasonography blood flow analyzers.In clinical applications, Delica's "Starry Academy" collaborates with experts from around the world to conduct nearly 50 online academic live broadcasts each year, helping to improve the clinical diagnostic capabilities of grassroots hospitals.After years of dedication, Delica’s users now cover dozens of countries and regions across five continents globally. Its Transcranial Doppler products maintain leading market shares in mainstream international markets such as China, the United States, and South Korea.In September 2021, Delica was recognized by the Ministry of Industry and Information Technology as a national-level specialized, refined, distinctive, and innovative key "Little Giant" enterprise!Delica, leading the future of brain technology with intelligence!